Nuclear factor of activated T cells 1 (NFAT1)-induced Permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation

Journal of Biological Chemistry

Volumn 287, Issue 19, 2012, Pages 15445-15457

  Jash, Arijita ^a   Sahoo, Anupama ^a,b   Kim, Gi Cheon ^a   Chae, Chang Suk ^a   Hwang, Ji Sun ^a   Kim, Jung Eun ^a   Im, Sin Hyeog ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION COMPLEX; CHROMATIN MODIFICATION; CORE PROTEINS; DOWN-REGULATION; GENE TRANSCRIPTIONS; IN-VIVO; INFLAMMATORY IMMUNE RESPONSE; MOLECULAR MECHANISM; NUCLEAR FACTOR OF ACTIVATED T-CELLS; NUCLEAR FACTORS; PATHOPHYSIOLOGICAL; T CELLS; TRANSACTIVATION; TRANSCRIPTION ACTIVATORS; TRANSCRIPTIONALLY ACTIVE;

GENES;

TRANSCRIPTION;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 9; MESSENGER RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTATION; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION;

EID: 84860851543     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.340356     Document Type: Article

References (77)

1. Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger A, Strom, T. B., Oukka, M., and Kuchroo, V. K. (2007) IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484-487 (Pubitemid 47123515)
2. Sutton, C., Brereton, C., Keogh, B., Mills, K. H., and Lavelle, E. C. (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (Pubitemid 44036274)
3. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., and Iwakura, Y. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573 (Pubitemid 43939170)
4. + T cell lineage differentiation. Immunity 30, 646-655
5. - effector T cells. Nat. Immunol. 9, 1347-1355
6. Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., and Stockinger, B. (2008) Transforming growth factor-β "reprograms" the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346
7. Nowak, E. C., and Noelle, R. J. (2009) Interleukin-9 and T cell subsets. Cell Cycle 8, 3798-3799
8. Renauld, J. C., Druez, C., Kermouni, A., Houssiau, F., Uyttenhove, C., Van Roost, E., and Van Snick, J. (1992) Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc. Natl. Acad. Sci. U.S.A. 89, 5690-5694
9. Renauld, J. C., Kermouni, A., Vink, A., Louahed, J., and Van Snick, J. (1995) Interleukin-9 and its receptor. Involvement in mast cell differentiation and T cell oncogenesis. J. Leukoc. Biol. 57, 353-360
10. Hültner, L., Druez, C., Moeller, J., Uyttenhove, C., Schmitt, E., Rüde, E., Dörmer, P., and Van Snick, J. (1990) Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur. J. Immunol. 20, 1413-1416 (Pubitemid 20206111)
11. Uyttenhove, C., Simpson, R. J., and Van Snick, J. (1988) Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc. Natl. Acad. Sci. U.S.A. 85, 6934-6938
12. Hauber, H. P., Bergeron, C., and Hamid Q. (2004) IL-9 in allergic inflammation. Int. Arch. Allergy Immunol. 134, 79-87 (Pubitemid 38698101)
13. Steenwinckel, V., Louahed, J., Lemaire, M. M., Sommereyns, C., Warnier, G., McKenzie, A., Brombacher, F., Van Snick, J., and Renauld, J. C. (2009) IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J. Immunol. 182, 4737-4743
14. Temann, U. A., Laouar, Y., Eynon, E. E., Homer, R., and Flavell, R. A. (2007) IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 19, 1-10 (Pubitemid 46017882)
15. Townsend, J. M., Fallon, G. P., Matthews, J. D., Smith, P., Jolin, E. H., and McKenzie, N. A. (2000) IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13, 573-583
16. + natural regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 106, 12885-12890
17. Li, H., Nourbakhsh, B., Ciric, B., Zhang, G. X., and Rostami, A. (2010) Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J. Immunol. 185, 4095-4100
18. Nowak, E. C., Weaver, C. T., Turner, H., Begum-Haque, S., Becher, B., Schreiner, B., Coyle, A. J., Kasper, L. H., and Noelle, R. J. (2009) IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206, 1653-1660
19. Eller, K., Wolf, D., Huber, J. M., Metz, M., Mayer, G., McKenzie, A. N., Maurer, M., Rosenkranz, A. R., and Wolf, A. M. (2011) IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J. Immunol. 186, 83-91
20. Noelle, R. J., and Nowak, E. C. (2010) Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 10, 683-687
21. Chang, H. C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A. N., Han, L., Nguyen, E. T., Robertson, M. J., Perumal, N. B., Tepper, R. S., Nutt, S. L., and Kaplan, M. H. (2010) The transcription factor PU.1 is required for the development of IL-9- producing T cells and allergic inflammation. Nat. Immunol. 11, 527-534
22. Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., Dehzad, N., Becker, M., Stassen, M., Steinborn, A., Lohoff, M., Schild, H., Schmitt, E., Bopp, T. (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192-202
23. Goswami, R., Jabeen, R., Yagi, R., Pham, D., Zhu, J., Goenka, S., and Kaplan, M. H. (2012) STAT6-dependent regulation of Th9 development. J. Immunol. 188, 968-975
24. Perumal, N. B., and Kaplan, M. H. (2011) Regulating Il9 transcription in T helper cells. Trends Immunol. 32, 146-150
25. + T helper cell effector functions. Blood 115, 2989-2997
26. Macian, F. (2005) NFAT proteins. Key regulators of T-cell development and function. Nat. Rev. Immunol. 5, 472-484
27. 2+/calcineurin-NFAT-mediated signaling. Mol. Cells 18, 1-9
28. Cantrell, D. (1996) T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14, 259-274
29. Weiss, A., and Littman, D. R. (1994) Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274 (Pubitemid 24046689)
30. Lee, C. G., Kang, K. H., So, J. S., Kwon, H. K., Son, J. S., Song, M. K., Sahoo, A., Yi, H. J., Hwang, K. C., Matsuyama, T., Yui, K., and Im, S. H. (2009) A distal cis-regulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL-10 gene activation in T helper cells. Mol. Immunol. 46, 613-621
31. Rengarajan, J., Mowen, K. A., McBride, K. D., Smith, E. D., Singh, H., and Glimcher, L. H. (2002) Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003-1012 (Pubitemid 34412002)
32. Tone, Y., Furuuchi, K., Kojima, Y., Tykocinski, M. L., Greene, M. I., and Tone, M. (2008) Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194-202
33. Mehta, D. S., Wurster, A. L., Weinmann, A. S., and Grusby, M. J. (2005) NFATc2 and T-bet contribute to T-helper cell subset-specific regulation of IL-21 expression. Proc. Natl. Acad. Sci. U.S.A. 102, 2016-2021 (Pubitemid 40262004)
34. García-Rodríguez, C., and Rao, A. (1998) Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J. Exp. Med. 187, 2031-2036 (Pubitemid 28285572)
35. Köenig, A., Linhart, T., Schlengemann, K., Reutlinger, K., Wegele, J., Adler, G., Singh, G., Hofmann, L., Kunsch, S., Büch, T., Schäfer, E., Gress, T. M., Fernandez-Zapico, M. E., and Ellenrieder, V. (2010) NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology 138, 1189-1199
36. Rao, A., Luo, C., and Hogan, P. G. (1997) Transcription factors of the NFAT family. Regulation and function. Annu. Rev. Immunol. 15, 707-747 (Pubitemid 27169297)
37. Gessner, A., Blum, H., and Röllinghoff, M. (1993) Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189, 419-435 (Pubitemid 24008832)
38. Kadereit, S., Mohammad, S. F., Miller, R. E., Woods, K. D., Listrom, C. D., McKinnon, K., Alali, A., Bos, L. S., Iacobucci, M. L., and Sramkoski, M. R. (1999) Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 94, 3101-3107 (Pubitemid 29512716)
39. + T lymphocytes during primary stimulation. Blood 102, 4608-4617
40. Baldwin, A. S., Jr. (1996) The NF-κB and IκB proteins. New discoveries and insights. Annu. Rev. Immunol. 14, 649-683
41. Baeuerle, P. A., and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179
42. Grumont, R. J., and Gerondakis, S. (2000) Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes. Modulation of interferon-regulated gene expression by Rel/nuclear factor κB. J. Exp. Med. 191, 1281-1292
43. Sun, S. C., and Yamaoka, S. (2005) Activation of NF-κB by HTLV-I and implications for cell transformation. Oncogene 24, 5952-5964
44. Gao, Z., Chiao, P., Zhang, X., Zhang, X., Lazar, M. A., Seto, E., Young, H. A., and Ye, J. (2005) Coactivators and corepressors of NF-KB in IkBαgene promoter. J. Biol. Chem. 280, 21091-21098 (Pubitemid 40805668)
45. Na, S. Y., Lee, S. K., Han, S. J., Choi, H. S., Im, S. Y., and Lee, J. W. (1998) Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor κB-mediated transactivations. J. Biol. Chem. 273, 10831-10834
46. Stassen, M., Müller, C., Arnold, M., Hültner, L., Klein-Hessling, S., Neudörfl, C., Reineke, T., Serfling, E., and Schmitt, E. (2001) IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide. NF-κB is decisively involved in the expression of IL-9. J. Immunol. 166, 4391-4398 (Pubitemid 32233721)
47. Zhu, Y. X., Kang, L. Y., Luo, W., Li, C. C., Yang, L., and Yang, Y. C. (1996) Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J. Biol. Chem. 271, 15815-15822 (Pubitemid 26226719)
48. Frazer, K. A., Pachter, L., Poliakov, A., Rubin, E. M., and Dubchak, I. (2004) VISTA. Computational tools for comparative genomics. Nucleic Acids Res. 32, W273-W279 (Pubitemid 38997343)
49. Demoulin, J. B., Van Roost, E., Stevens, M., Groner, B., and Renauld, J. C. (1999) Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9. J. Biol. Chem. 274, 25855-25861
50. Im, S. H., Hueber, A., Monticelli, S., Kang, K. H., and Rao, A. (2004) Chromatin-level regulation of the IL10 gene in T cells. J. Biol. Chem. 279, 46818-46825 (Pubitemid 39518332)
51. Sahoo, A., Lee, C. G., Jash, A., Son, J. S., Kim, G., Kwon, H. K., So, J. S., and Im, S. H. (2011) Stat6 and c-Jun Mediate Th2 Cell-specific IL-24 Gene Expression. J. Immunol. 186, 4098-4109
52. Lerner, L., Henriksen, M. A., Zhang, X., and Darnell, J. E. (2003) STAT3- dependent enhanceosome assembly and disassembly. Synergy withGRfor full transcriptional increase of the 2-macroglobulin gene. Genes Dev. 17, 2564-2577 (Pubitemid 37271426)
53. Xu, L., Han, C., Lim, K., and Wu, T. (2006) Cross-talk between peroxisome proliferator-activated receptor and cytosolic phospholipase A2/cyclooxygenase- 2/prostaglandin E2 signaling pathways in human hepatocellular carcinoma cells. Cancer Res. 66, 11859-11868 (Pubitemid 46094198)
54. Timmerman, L. A., Healy, J. I., Ho, S. N., Chen, L., Goodnow, C. C., and Crabtree, G. R. (1997) Redundant expression but selective utilization of nuclear factor of activated T cell family members. J. Immunol. 159, 2735-2740 (Pubitemid 127681293)
55. Macián F, García-Cózar, F., Im, S. H., Horton, H. F., Byrne, M. C., and Rao, A. (2002) Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731 (Pubitemid 34722268)
56. Holz, L. E., Jakobsen, K. P., Van Snick, J., Cormont, F., and Sewell, W. A. (2005) Dexamethasone inhibits IL-9 production by human T cells. J. Inflamm. (Lond) 2, 1-9
57. Monteyne, P., Renauld, J. C., Van Broeck, J., Dunne, D. W., Brombacher, F., and Coutelier, J. P. (1997) IL-4-independent regulation of in vivo IL-9 expression. J. Immunol. 159, 2616-2623 (Pubitemid 127681279)
58. Rao, S., Gerondakis, S., Woltring, D., and Shannon, M. F. (2003) c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J. Immunol. 170, 3724-3731 (Pubitemid 36359242)
59. Workman, J. L., and Kingston, R. E. (1998) Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67, 545-579 (Pubitemid 28411138)
60. Wong, M. T., Ye, J. J., Alonso, M. N., Landrigan, A., Cheung, R. K., Engleman, E., and Utz, P. J. (2010) Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol. Cell Biol. 88, 624-631
61. Johnson, B. V., Bert, A. G., Ryan, G. R., Condina, A., and Cockerill, P. N. (2004) Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol. Cell Biol. 24, 7914-7930 (Pubitemid 39167442)
62. Cron, R. Q., Bartz, S. R., Clausell, A., Bort, S. J., Klebanoff, S. J., and Lewis, D. B. (2000) NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Clin. Immunol. 94, 179-191 (Pubitemid 30141746)
63. Farrow, M. A., Kim, E. Y., Wolinsky, S. M., and Sheehy, A. M. (2011) NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G. J. Biol. Chem. 286, 2567-2577
64. Gibson, H. M., Hedgcock, C. J., Aufiero, B. M., Wilson, A. J., Hafner, M. S., Tsokos, G. C., and Wong, H. K. (2007) Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter. J. Immunol. 179, 3831-3840
65. Chan, H. M., and La Thangue, N. B. (2001) p300/CBP proteins. HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114, 2363-2373 (Pubitemid 32684792)
66. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. U.S.A. 94, 2927-2932 (Pubitemid 27157241)
67. Chen, L., Mu, Y., and Greene, W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21, 6539-6548 (Pubitemid 35448431)
68. Macián, F., López-Rodriguez, C., and Rao, A. (2001) Partners in transcription. NFAT and AP-1. Oncogene 20, 2476-2489
69. Sica, A., Dorman, L., Viggiano, V., Cippitelli, M., Ghosh, P., Rice, N., and Young, H. A. (1997) Interaction of NF-kappaB and NFAT with the interferon- γ promoter. J. Biol. Chem. 272, 30412-30420 (Pubitemid 27512251)
70. McCaffrey, P. G., Jain, J., Jamieson, C., Sen, R., and Rao, A. (1992) AT cell nuclear factor resembling NF-AT binds to an NF-κB site and to the conserved lymphokine promoter sequence cytokine-1. J. Biol. Chem. 267, 1864-1871
71. Tsytsykova, A. V., Rajsbaum, R., Falvo, J. V., Ligeiro, F., Neely, S. R., and Goldfeld, A. E. (2007) Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers. Proc. Natl. Acad. Sci. U.S.A. 104, 16850-16855 (Pubitemid 350210954)
72. Hogan, P. G., Chen, L., Nardone, J., and Rao, A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232 (Pubitemid 37128637)
73. Cakouros, D., Cockerill, P. N., Bert, A. G., Mital, R., Roberts, D. C., and Shannon, M. F. (2001) An NF-κB/Sp1 region is essential for chromatin remodeling and correct transcription of a human granulocyte-macrophage colony-stimulating factor transgene. J. Immunol. 167, 302-310 (Pubitemid 32567793)
74. Carey, M., and Smale, S. T. (2002) Transcriptional Regulation in Eukaryotes: Concepts, Strategies, and Techniques, 1st Ed., pp. 144-145, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
75. Ishihara, S., and Schwartz, R. H. (2011) Two-step binding of transcription factors causes sequential chromatin structural changes at the activated IL-2 promoter. J. Immunol. 187, 3292-3299
76. Stephens, G. L., Swerdlow, B., Benjamin, E., Coyle, A. J., Humbles, A., Kolbeck, R., and Fung, M. (2011) IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ specific autoimmune disease. Eur. J. Immunol. 41, 952-962
77. Refaat, A., Zhou, Y., Suzuki, S., Takasaki, I., Koizumi, K., Yamaoka, S., Tabuchi, Y., Saiki, I., and Sakurai, H. (2011) Distinct roles of transforming growth factor-β-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9. J. Biol. Chem. 286, 21092-21099